Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Services
  • Locations
  • Physicians
  • Patient and Visitor Info
  • Clinical Trials
  • Event Calendar
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Physicians > Lien, Lillian F.
Jumbo Large Regular Text:
Print E-mail
Physicians

Lillian F. Lien, MD

Related Content

Services

  • Endocrinology

Health Library

  • Diet Soda: Too Good to Be True?

Share

Lillian F. Lien, MD

Medical Director, Duke Inpatient Diabetes Management

Department / Division
Medicine / Med - Endocrinology & Metab

Address
DUMC 2956
Durham, NC 27710

Appointment Telephone
Not accepting new patients

Office Telephone
919-684-9036

Fax Telephone
919-681-7796

Training
  • MD, Duke University School of Medicine, 1999

Residency
  • Internal Medicine, Duke University Medical Center, 1999-2002

Fellowship
  • Endocrinology, Metabolism, and Nutrition, Duke University Medical Center, 2002-2005

Clinical Interests
Safe use of intravenous insulin and subcutaneous insulin, all aspects of diabetes in the hospital, obesity, metabolomics, metabolic syndrome

Research Interests
Lillian Lien, MD is an Assistant Professor in the Duke Department of Medicine, a faculty member of the Division of Endocrinology, Metabolism and Nutrition, and a faculty member of the Sarah W. Stedman Nutrition and Metabolism Center.  Lillian completed Internal Medicine Residency and Endocrinology Fellowship training at Duke University Medical Center.   She has long had an interest in quantitative research, beginning with her undergraduate work at Harvard University in Biomedical Engineering. Throughout her medical career, she has devoted her efforts to clinical research and translational projects. In 2001, she received the Barton Haynes Research Support Award for her innovative work in optimizing the safe administration of intravenous insulin. Her other research priorties focus on obesity and metabolism, with a specific interest in the metabolic syndrome and the link between adipocytokines and insulin resistance. She is a key member of the STEDMAN Project team and is involved in wide-ranging project issues from project design to supervising and instructing junior staff. She also received the 2006 Haynes Early Career Research Grant for junior faculty in the Duke Department of Medicine.

Industry Relationships and Collaborations (What's this?)

This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

  • Access Medical Group, Ltd
  • Carolinas Medical Center
  • Eli Lilly & Co.
  • Merck & Co. USA (not assoc'd with Merck KGaA)
  • Novo Nordisk
  • Sanofi-Aventis

Representative Publications
Lien LF, Brown AJ, Ard JD, Loria C, Erlinger TP, Feldstein AC, Lin PH, Champagne CM, King AC, McGuire HL, Stevens VJ, Brantley PJ, Harsha DW, McBurnie MA, Appel LJ, Svetkey LP. Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome. Hypertension. 2007 Oct;50(4):609-16. (2007) Abstract

Lien LF, Lane JD. “Pharmacologic factors affecting glycemic control.” Chapter in Type 2 Diabetes Mellitus: An Evidence-Based Approach to Practical Management, eds. Feinglos MN and Bethel MA, IN PRESS. (2007)

Davis ED, Harwood K, Midgett L, Mabrey M, Lien LF. Implementation of a new intravenous insulin method on intermediate-care units in hospitalized patients. Diabetes Educ. 2005 Nov-Dec;31(6):818-21, 823. (2005) Abstract

Haqq AM, Lien LF, Boan J, Arlotto M, Slentz CA, Muehlbauer MJ, Rochon J, Gallup D, McMahon RL, Bain JR, Stevens R, Millington D, Butler MD, Newgard CB, Svetkey LP. The Study of the Effects of Diet on Metabolism and Nutrition (STEDMAN) weight loss project: Rationale and design. Contemp Clin Trials. 2005 Dec;26(6):616-25. (2005) Abstract

Lien L, Feinglos M. “Management of Obesity-Associated Type 2 Diabetes.”  Chapter 12 in Nutrition and Diabetes:Pathophysiology and Management, ed. Opara E., CRC press: Boca Raton, FL, p.205-225, 2005 (2005)

Lien LF, Feinglos MN. Protease inhibitor-induced diabetic complications : incidence, management and prevention. Drug Saf. 2005;28(3):209-26. (2005) Abstract

Lien LF, Spratt SE, Woods Z, Osborne KK, Feinglos MN. Optimizing hospital use of intravenous insulin therapy: improved management of hyperglycemia and error reduction with a new nomogram. Endocr Pract. 2005 Jul-Aug;11(4):240-53. (2005) Abstract

Lien LF, Angelyn Bethel M, Feinglos MN. In-hospital management of type 2 diabetes mellitus. Med Clin North Am. 2004 Jul;88(4):1085-105, xii. (2004) Abstract

Lien LF, Whitson HE, Grant AG, McNeill DB. Multiple endocrine neoplasia type 1 manifesting with chronic and persistent diarrhea. Endocr Pract. 2004 Jan-Feb;10(1):83-4. (2004) Abstract

Robinson RA, Stewart SF, Myers MR, Lien LF, Rinaldi JR, Swisher JL, Drasner K. In vitro modeling of spinal anesthesia. A digital video image processing technique and its application to catheter characterization. Anesthesiology. 1994 Oct;81(4):1053-60. (1994) Abstract

Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En Español | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2012 Duke University Health System

About This Page

Updated: Nov. 2, 2010
Published: Dec. 12, 2006
URL: http://www.dukehealth.org/physicians/lillian_f_lien